The Bulletin
The Times


.

Connext Completes Enrollment in Phase 2 Trial of CNT201 in Dupuytren's Contracture

  • Written by PR Newswire

- All 56 planned participants enrolled approximately five months after first patient dosing

- Topline Phase 2 data expected in late 2026

- Positive data could support expansion of CNT201 into Peyronie's disease and cellulite

SEOUL, South Korea, Aug. 17, 2026 /PRNewswire/ -- Connext, a specialty therapeutics company focused on developing innovative...

The Bulletin Magazine

The Essential Bathroom Renovation Supplies Checklist Before You Start

Pull Up Stands: A Convenient Display Option for Events and Promotions

How Mining Hose Selection Can Improve Material Transfer Systems

Electric Sliding Door: What to Consider Before Choosing One

What Is Included in a Professional Roof Repair Service on the Gold Coast?

The Unglamorous Baby Buys That Save Australian Parents the Most Time

Cryptocurrency Trading in 2026_ Why Regulated Education Is the New Standard

How Mining Hose Routing Can Influence Wear and Transfer Efficiency

Cryotherapy in Melbourne: What Skin Lesions Can Be Treated with Targeted Cold Therapy?

10 Restaurants in Cranbourne You Need to Try Before 2027

ZOLL Defibrillators: Why They're a Leading Choice for Businesses, Warehouses, and Healthcare Settings

How Property Maintenance Issues Can Affect Commercial Tenancies

hacklink hack forum hacklink film izle hacklink PadişahbetcasibomRoyal reelsThe PokiesBetpipoBetpipoVipparkPadişahbetGalabetimajbetcasibomcasibomcasinos not on gamstopnon uk casinosnot on gamstopcasinos not on gamstopcasinos non gamblock ukiptvcanlı maç izlezlibraryzlibraryz-libraryankara escortdeneme bonusuPadişahbetVipparkPadişahbetDeneme bonusuperabetPadişahbetmarsbahistaraftarium24jojobetmarsbahisSahabetjojobetsuperbetinmatbetjojobet